Akashi, Japan

Itaru Urabe


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 153(Granted Patents)


Company Filing History:


Years Active: 1992-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Itaru Urabe: Innovator in Biopolymer Synthesis

Introduction

Itaru Urabe is a notable inventor based in Akashi, Japan. He has made significant contributions to the field of biopolymer synthesis, holding a total of 2 patents. His work focuses on innovative methods that enhance the production and application of biopolymers.

Latest Patents

Urabe's latest patents include a seamless capsule for synthesizing biopolymer and a method for producing the same. Additionally, he has developed a recombinant DNA that is replicable and expressible in Escherichia coli. This DNA encodes glucose dehydrogenase originating from Bacillus megaterium. The process involves incorporating a DNA sequence encoding glucose dehydrogenase into an E. coli vector, which is then used to transform an E. coli host. Furthermore, his patents disclose transformants and recombinant DNA that incorporate thermostable glucose dehydrogenase, wherein at least one amino acid in glucose dehydrogenase at positions 96, 252, and 253 is replaced by a thermostability-conferring amino acid.

Career Highlights

Throughout his career, Urabe has worked with prominent companies such as Morishita Jintan Co., Ltd. and Amano Pharmaceutical Co., Ltd. His expertise in biopolymer synthesis has positioned him as a key figure in the industry.

Collaborations

Urabe has collaborated with notable individuals in his field, including Tetsuya Yomo and Keizo Yamamoto. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Itaru Urabe's contributions to biopolymer synthesis and recombinant DNA technology highlight his role as an influential inventor. His patents and collaborations reflect his commitment to advancing scientific knowledge and practical applications in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…